Based on data from the past 90 days ending February 10, 2026, Solid Biosciences's three largest insider shareholders are Director Advisors Llc Perceptive (11.83Mn shares), TenPercentOwner Capital Life Sciences Investors, Llc Bain (5.03Mn shares), TenPercentOwner Capital Management, L.P. Adage (4.25Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Advisors Llc Perceptive | 11,833,539 | 21 Feb, 2025 | |
| Capital Life Sciences Investors, Llc Bain | 5,034,582 | 21 Feb, 2025 | |
| Capital Management, L.P. Adage | 4,248,084 | 19 Feb, 2025 | |
| Capital Management, L.P. Ra | 4,192,216 | 12 Jan, 2024 | |
| Adam Koppel | 4,034,582 | 12 Jan, 2024 | |
| Joel Solomon Zev Schneider | Chief Operating Officer | 15,752 | 15 Mar, 2022 |
| Alexander Cumbo | President And Ceo | 222,018 | 06 Feb, 2026 |
| Ian F Smith | 131,264 | 07 Jan, 2026 | |
| Ilan Ganot | 124,568 | 30 Jan, 2026 | |
| David T Howton | Chief Operating Officer | 97,859 | 06 Feb, 2026 |
| Kevin Tan | Cfo & Treasurer | 94,201 | 06 Feb, 2026 |
| Gabriel Brooks | Chief Medical Officer | 84,092 | 06 Feb, 2026 |
| Jessie Hanrahan | Chief Regulatory Officer | 70,327 | 06 Feb, 2026 |
| Paul Herzich | Chief Technology Officer | 69,067 | 06 Feb, 2026 |
| Carl Ashley Morris | Chief Scientific Officer | 19,760 | 31 Jan, 2023 |
| Jennifer Marlowe | Cso | 6,998 | 05 Dec, 2023 |
| Clare Kahn | 2,960 | 13 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Feb, 2026 | David T Howton | Common Stock | D | 18,894 | $6.44 | 97,859 | D | S |
| 04 Feb, 2026 | Alexander Cumbo | Common Stock | D | 48,913 | $6.44 | 222,018 | D | S |
| 04 Feb, 2026 | Ilan Ganot | Common Stock | D | 7,205 | $6.44 | 25,271 | I | S |
| 04 Feb, 2026 | Kevin Tan | Common Stock | D | 14,783 | $6.44 | 94,201 | D | S |
| 04 Feb, 2026 | Jessie Hanrahan | Common Stock | D | 12,348 | $6.44 | 70,327 | D | S |
| 04 Feb, 2026 | Paul Herzich | Common Stock | D | 10,905 | $6.44 | 69,067 | D | S |
| 04 Feb, 2026 | Gabriel Brooks | Common Stock | D | 12,616 | $6.44 | 84,092 | D | S |
| 02 Feb, 2026 | David T Howton | Common Stock | D | 37,771 | $6.44 | 116,753 | D | S |
| 02 Feb, 2026 | Alexander Cumbo | Common Stock | D | 80,258 | $6.44 | 270,931 | D | S |
| 02 Feb, 2026 | Kevin Tan | Common Stock | D | 26,837 | $6.44 | 108,984 | D | S |
| 02 Feb, 2026 | Jessie Hanrahan | Common Stock | D | 26,535 | $6.44 | 82,675 | D | S |
| 02 Feb, 2026 | Paul Herzich | Common Stock | D | 26,250 | $6.44 | 79,972 | D | S |
| 02 Feb, 2026 | Gabriel Brooks | Common Stock | D | 28,335 | $6.44 | 96,708 | D | S |
| 31 Jan, 2026 | David T Howton | Common Stock | A | 42,275 | - | 154,254 | D | M |
| 31 Jan, 2026 | Alexander Cumbo | Common Stock | A | 100,400 | - | 351,189 | D | M |
| 31 Jan, 2026 | Ilan Ganot | Common Stock | A | 15,000 | - | 32,476 | I | M |
| 31 Jan, 2026 | Kevin Tan | Common Stock | A | 33,075 | - | 135,821 | D | M |
| 31 Jan, 2026 | Jessie Hanrahan | Common Stock | A | 27,625 | - | 109,210 | D | M |
| 31 Jan, 2026 | Paul Herzich | Common Stock | A | 24,675 | - | 106,222 | D | M |
| 31 Jan, 2026 | Gabriel Brooks | Common Stock | A | 28,225 | - | 125,043 | D | M |